Elinzanetant approved as first dual NK-1 and NK-3 blocker for menopausal hot flashes
A new drug profile describes elinzanetant as the first dual NK-1 and NK-3 receptor antagonist approved for moderate to severe ...
Tag: NK-1 receptor
POPULAR NEWS
-
Blood sedimentation rate predicts death risk in dogs with chronic kidney disease
-
Poor Preoperative Nutrition Linked to Higher Complications and Lower Survival After Hip Replacement
-
New DARPA-funded project aims to cut AI energy use by up to half
-
Antarctic Pond Bacterium Survives Calcium Levels Once Thought Fatal to Life